HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Caffeine restriction has no role in the management of patients with symptomatic idiopathic ventricular premature beats.

AbstractOBJECTIVE:
To assess the role of caffeine restriction in the management of patients with symptomatic idiopathic ventricular premature beats.
DESIGN:
A randomised, double blind, 6 week intervention trial incorporating dietary caffeine restriction, caffeinated coffee, and decaffeinated coffee.
SETTING:
Cardiac outpatient clinic.
PATIENTS:
13 patients with symptomatic frequent idiopathic ventricular premature beats.
MAIN OUTCOME MEASURES:
Weekly measures of serum caffeine concentration, coffee consumption, visual analogue score of palpitations, and 24 hour ventricular premature beat frequency.
RESULTS:
The interventions achieved significant alterations in serum caffeine concentrations (P < 0.001) which correlated with coffee consumption (r = 0.70; P < 0.001). Visual analogue palpitation scores showed a small, but significant correlation with ventricular premature beat frequencies (r = 0.34; P = 0.003). However, there were no significant changes in palpitation scores or ventricular premature beat frequencies during the intervention weeks and no significant correlations were found between these variables and serum caffeine concentrations.
CONCLUSIONS:
Caffeine restriction has no role in the management of patients referred with symptomatic idiopathic ventricular premature beats.
AuthorsD E Newby, J M Neilson, D R Jarvie, N A Boon
JournalHeart (British Cardiac Society) (Heart) Vol. 76 Issue 4 Pg. 355-7 (Oct 1996) ISSN: 1355-6037 [Print] England
PMID8983684 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Caffeine
Topics
  • Caffeine (administration & dosage, blood)
  • Diet
  • Double-Blind Method
  • Electrocardiography, Ambulatory
  • Female
  • Humans
  • Male
  • Middle Aged
  • Ventricular Premature Complexes (blood, physiopathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: